Business Wire
BusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex TimesBusinessAmgen vs. Eli Lilly: GLP-1 obesity-drug hype is reshaping how investors price two biotech giantsThe Apex TimesBusinessNetflix stock climbs after profitability beat, even as investors weigh guidance riskThe Apex TimesBusinessBoeing set for next-week earnings, with analysts forecasting double-digit growth in key profit measureThe Apex TimesBusinessDisney stock edges higher after a market dip, closing up 1% in latest sessionThe Apex TimesBusinessBoeing shares slip more than the overall market as investors weigh company-specific concernsThe Apex TimesBusinessWhy Deere (DE) rose even as broader markets dipped on the dayThe Apex TimesBusinessBerkshire Hathaway B shares rise even as market pulls back, closing at $546.90The Apex TimesBusinessBroadcom shares fall more than the broader market in latest session, AVGO closes down 4.3%The Apex TimesBusinessCoca-Cola (KO) gains after market dips as shares settle at $95.34The Apex TimesBusinessCommentary Links Spotify’s Share Move to Its “Simple Formula,” as Investors Focus on the Streaming MixThe Apex TimesBusinessPfizer’s Revenue Dip Versus Bristol Myers Squibb’s Steady Climb Highlights a Consistency-Scale TradeoffThe Apex TimesBusinessSalesforce plans to buy Braze in a deal valued around $5.66 billion, aiming to deepen real-time AI marketingThe Apex Times
Back to front
Bill Ackman Says Meta Can Fund Its AI Plans, Citing About $82 Billion in Cash and Securities
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 22, 5:27 PM EDT

Bill Ackman Says Meta Can Fund Its AI Plans, Citing About $82 Billion in Cash and Securities

The Pershing Square founder told investors he believes Meta Platforms has the balance-sheet capacity to pursue large-scale artificial intelligence spending, pointing to a reported pile of cash and marketable securities.

Billionaire investor Bill Ackman said Meta Platforms Inc. appears financially able to fund “whatever they want” as it ramps up artificial intelligence investments, pointing to what he described as roughly $82 billion in cash and securities. Ackman’s comments, reported by Yahoo Finance via Benzinga, frame Meta’s financial resources as a buffer for an aggressive AI push rather than a constraint.

Ackman’s central argument is that Meta’s available liquidity would allow it to maintain or increase spending on AI without being forced into immediate cuts or financing maneuvers. In his view, the company can continue investing through different market cycles because it holds substantial cash and marketable financial assets.

The remarks come as Meta has positioned generative AI and AI infrastructure as a key part of its longer-term product and business strategy. While Ackman focused on balance-sheet strength, investors have broadly been watching whether the company’s AI spending pace is sustainable and how quickly it could translate into higher engagement, ad performance, or new revenue streams.

The reported figure of about $82 billion in cash and securities also serves as a reference point for how investors may underwrite Meta’s risk profile. Large AI programs can be costly, especially when they require ongoing spending on data, computing capacity, and talent. Ackman’s emphasis suggests that, for him, Meta’s cash cushion reduces the downside from short-term cost pressure.

Meta has not publicly linked the size of its AI ambitions to any single liquidity threshold in the reporting referenced here. In the absence of a detailed, primary document in the post described, it is unclear whether Ackman’s $82 billion framing matches a specific accounting line item at a precise reporting date, or whether it represents a combined figure that may fluctuate over time.

Company context matters because Meta’s AI work spans multiple areas, including models used across its platforms and the systems needed to deliver them at scale. The company’s AI agenda, like that of peers, also intersects with data center investment and hardware procurement, which can create multi-year spending commitments.

The most important takeaway from Ackman’s comments is not a new spending target, but a confidence claim. He portrayed Meta’s financial flexibility as sufficient to support extensive AI spending, even if such spending remains heavy relative to near-term returns.

What is not disclosed in the reporting summarized here is the specific dollar amount Meta plans to spend on AI over any defined period, how management expects to fund incremental capex beyond existing liquidity, or what performance benchmarks would determine whether spending accelerates or slows. Investors will likely watch for company guidance, capital expenditure updates, and disclosures tied to AI infrastructure costs to clarify how the balance-sheet capacity translates into an execution plan.

Why It Matters

  • If accurate, the scale of Meta’s cash and marketable securities could affect how investors evaluate the risk of continued AI spending.
  • Ackman’s framing may influence market expectations around Meta’s ability to sustain high spending without immediate financing constraints.
  • The comments underscore that AI investment decisions are being assessed not only on expected returns, but also on balance-sheet capacity and execution runway.
  • Without disclosed targets, investors still face uncertainty about the pace of AI spending and the timing of any measurable business impact.

Sources

Key Facts

  • Bill Ackman said Meta can financially fund “whatever they want” as it pursues artificial intelligence ambitions.
  • The comments point to roughly $82 billion in cash and securities as the basis for that assessment.
  • The remarks were reported by Yahoo Finance via Benzinga on Oct. 22, 2026.
  • The discussion centered on financial flexibility rather than a specific, disclosed AI spending budget or timeline.
  • The referenced reporting does not provide detailed, primary-source financial documentation or an exact accounting breakdown tied to the $82 billion figure.

Technology Related